idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
Science Campus Braunschweig-Süd will be strengthened as a center for development and manufacturing of modern biopharmaceutical products
The Helmholtz Centre for Infection Research (HZI) welcomes the acquisition of the Braunschweig site of the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) by AveThera GmbH, effective March 16, 2026, as an important step for the region and particularly for the Science Campus Braunschweig-Süd. Core competencies in pharmaceutical biotechnology will remain in Braunschweig, while the Science Campus will be further strengthened as a center for the development and manufacturing of modern biopharmaceutical products.”
With the acquisition, responsibility for the site transfers to a young privately owned company. AveThera plans to strategically expand the existing expertise and infrastructure to advance innovative biopharmaceutical solutions. The new owner brings additional perspectives and resources that will enable optimal use of the existing technologies and specialized know-how.
“It is a strong signal that the production capacities and the highly qualified employees at the Braunschweig site will be retained,” says Christian Scherf, Administrative Director of the Helmholtz Centre for Infection Research. “The continuation of operations by AveThera strengthens the innovation campus and opens up new opportunities for collaboration between research and industrial development, as well as for the transfer of technology from research into application.”
Starting March 16, 2026, AveThera will continue production operations in the HZI facilities. Manufacturing will take place under GMP (“Good Manufacturing Practice”) conditions—international quality standards that ensure pharmaceuticals and medical products are produced reliably and safely. Existing capacities will be fully maintained, ensuring that specialized infrastructure, the expertise of experienced professionals, and industrial manufacturing capabilities will remain available at the site in the future.
Statement from AveThera
“The site at Science Campus Braunschweig-Süd offers excellent conditions for further developing modern biopharmaceutical manufacturing processes. We look forward to using the existing infrastructure, expanding our production capacities, and realizing new collaborative and innovation projects together with partners on the Science Campus,” explains AveThera GmbH.
AveThera intends to use the majority of its production capacity for its own product development while also making capacity available for external contract projects. This will create additional opportunities for collaboration with research institutions, spin-offs, and industry partners in the region.
About AveThera GmbH:
AveThera GmbH, headquartered in Hennigsdorf (Brandenburg), Germany, is a biopharmaceutical company specializing in the industrial manufacturing of complex biologics, including biosimilars for cancer treatment. With its own GMP production facility currently under development in Hennigsdorf, AveThera combines scientific expertise, proprietary process platforms, and modern manufacturing technologies to enable reliable and scalable supply of advanced biologics. The company also offers process development, GMP manufacturing, quality control and analytics, as well as scientific and technical consulting.
Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its other sites in Germany are engaged in the study of bacterial and viral infections and the body’s defense mechanisms. They have a profound expertise in natural compound research and its exploitation as a valuable source for novel anti-infectives. As member of the Helmholtz Association and the German Center for Infection Research (DZIF) the HZI performs translational research laying the ground for the development of new treatments and vaccines against infectious diseases. http://www.helmholtz-hzi.de/en
Contact:
Susanne Thiele, Spokesperson
susanne.thiele@helmholtz-hzi.de
+49 531 6181-1400
Dr Andreas Fischer, Editor
andreas.fischer@helmholtz-hzi.de
+49 531 6181-1405
https://www.helmholtz-hzi.de/en/media-center/newsroom/news-detail/hzi-welcomes-a... HZI press release
https://www.linkedin.com/company/avethera/ AveThera GmbH on LinkedIn
Aerial view of the Science Campus Braunschweig-Süd; in the foreground on the left is the building wh ...
Quelle: Verena Meier
Copyright: HZI/Verena Meier
Merkmale dieser Pressemitteilung:
Journalisten, Wirtschaftsvertreter, Wissenschaftler
Biologie, Chemie, Medizin
überregional
Organisatorisches
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
